EE03140B1 - Fosfolipiidderivaadid - Google Patents

Fosfolipiidderivaadid

Info

Publication number
EE03140B1
EE03140B1 EE9400199A EE9400199A EE03140B1 EE 03140 B1 EE03140 B1 EE 03140B1 EE 9400199 A EE9400199 A EE 9400199A EE 9400199 A EE9400199 A EE 9400199A EE 03140 B1 EE03140 B1 EE 03140B1
Authority
EE
Estonia
Prior art keywords
phospholipid derivatives
derivatives
phospholipid
medicaments
preparation processes
Prior art date
Application number
EE9400199A
Other languages
English (en)
Estonian (et)
Inventor
N�ssner Gerhard
Kutscher Bernhard
Engel J�rgen
Schumacher Wolfgang
Stekar Jurij
Hilgard Peter
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of EE03140B1 publication Critical patent/EE03140B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
EE9400199A 1992-07-11 1994-10-25 Fosfolipiidderivaadid EE03140B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4222910A DE4222910A1 (de) 1992-07-11 1992-07-11 Neue Phospholipidderivate

Publications (1)

Publication Number Publication Date
EE03140B1 true EE03140B1 (et) 1998-12-15

Family

ID=6463031

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400199A EE03140B1 (et) 1992-07-11 1994-10-25 Fosfolipiidderivaadid

Country Status (31)

Country Link
EP (1) EP0579939B1 (xx)
JP (1) JP3311431B2 (xx)
KR (1) KR100297180B1 (xx)
CN (1) CN1039012C (xx)
AT (1) ATE176477T1 (xx)
AU (1) AU664101B2 (xx)
BR (1) BR9302809A (xx)
CA (2) CA2100228C (xx)
CZ (1) CZ290863B6 (xx)
DE (2) DE4222910A1 (xx)
DK (1) DK0579939T3 (xx)
EE (1) EE03140B1 (xx)
ES (1) ES2129053T3 (xx)
FI (1) FI111262B (xx)
GR (1) GR3029602T3 (xx)
HR (1) HRP931046B1 (xx)
HU (1) HU218783B (xx)
IL (1) IL106289A (xx)
LT (1) LT3113B (xx)
LV (1) LV10870B (xx)
MX (1) MX9304133A (xx)
NO (1) NO306468B1 (xx)
PL (3) PL177811B1 (xx)
RU (1) RU2108336C1 (xx)
SG (1) SG46249A1 (xx)
SI (1) SI9300365B (xx)
SK (1) SK283827B6 (xx)
TW (1) TW304956B (xx)
UA (1) UA40567C2 (xx)
YU (1) YU49079B (xx)
ZA (1) ZA934971B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101146532B (zh) 2005-01-21 2012-05-09 阿斯泰克斯治疗有限公司 药物化合物
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
PL1962862T3 (pl) * 2005-12-19 2014-01-31 Aeterna Zentaris Gmbh Pochodne alkilofosfolipidów o ograniczonej cytotoksyczności i ich zastosowania
EP1869981A1 (de) * 2006-06-21 2007-12-26 Staatliches Weinbauinstitut Freiburg Alkylphospholipide und Lyso-Phospholipide zur Bekämpfung von Pflanzenpathogenen
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
EP0257762B1 (en) * 1986-07-14 1990-10-10 Nippon Chemiphar Co., Ltd. Novel glycerol derivative and anti-hypertensive agent
DE3881925T2 (de) * 1987-03-24 1994-01-27 Nippon Chemiphar Co Glycerol-Derivate und anti-hypertensives Mittel.
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4114586A1 (de) * 1991-05-04 1992-11-05 Boehringer Mannheim Gmbh Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
JP3311431B2 (ja) 2002-08-05
YU47393A (sh) 1997-08-22
EP0579939B1 (de) 1999-02-03
CZ290863B6 (cs) 2002-11-13
CA2100228A1 (en) 1994-01-12
LTIP620A (en) 1994-07-15
ZA934971B (en) 1994-02-01
UA40567C2 (uk) 2001-08-15
SI9300365B (sl) 2002-02-28
SG46249A1 (en) 1998-02-20
DE4222910A1 (de) 1994-01-13
RU2108336C1 (ru) 1998-04-10
PL173388B1 (pl) 1998-02-27
FI933165A (fi) 1994-01-12
HRP931046A2 (en) 1997-04-30
BR9302809A (pt) 1994-03-15
CA2511753C (en) 2007-09-25
PL177811B1 (pl) 2000-01-31
NO306468B1 (no) 1999-11-08
GR3029602T3 (en) 1999-06-30
MX9304133A (es) 1994-04-29
FI933165A0 (fi) 1993-07-09
YU49079B (sh) 2003-08-29
DE59309355D1 (de) 1999-03-18
EP0579939A1 (de) 1994-01-26
DK0579939T3 (da) 1999-09-20
SI9300365A (en) 1994-03-31
LV10870B (en) 1996-06-20
CN1039012C (zh) 1998-07-08
AU4186493A (en) 1994-01-13
ES2129053T3 (es) 1999-06-01
PL175607B1 (pl) 1999-01-29
JPH0733791A (ja) 1995-02-03
CA2511753A1 (en) 1994-01-12
CA2100228C (en) 2006-01-24
NO932502L (no) 1994-01-12
CN1084175A (zh) 1994-03-23
SK283827B6 (sk) 2004-02-03
KR940002265A (ko) 1994-02-17
HU218783B (hu) 2000-12-28
LT3113B (en) 1994-12-27
IL106289A0 (en) 1994-04-12
KR100297180B1 (ko) 2001-11-30
ATE176477T1 (de) 1999-02-15
FI111262B (fi) 2003-06-30
SK67093A3 (en) 1995-03-08
HU9301992D0 (en) 1993-09-28
TW304956B (xx) 1997-05-11
AU664101B2 (en) 1995-11-02
HRP931046B1 (en) 2000-06-30
LV10870A (lv) 1995-10-20
NO932502D0 (no) 1993-07-08
PL299624A1 (en) 1994-02-21
CZ124993A3 (en) 1995-03-15
HUT64548A (en) 1994-01-28
IL106289A (en) 2000-06-01

Similar Documents

Publication Publication Date Title
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
PT83872A (de) Arzneimittel
DE68920455D1 (de) Cyclohexenderivate.
ES544787A0 (es) Preparaciones medicinales solidas
DK0579939T3 (da) Phospholipidderivater
DE58902310D1 (de) Tetrahydropyridin-derivate.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
ATE66481T1 (de) Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20051231

HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231